Tilray Brands Expands Beverage Portfolio Through Acquisitions and New Product Launches

Tilray Brands accelerates beverage diversification with BrewDog acquisitions in UK & Australia, a new Pub Light lager, and a $1.2B revenue target by 2027.

Tilray Brands has announced a series of strategic moves in quick succession, signaling a focused push to diversify its revenue streams. The company is aggressively expanding its beverage segment, backed by new brand launches, acquisitions, and a clear long-term sales target.

Strategic Acquisitions Pave the Way for Global Growth

The cannabis and consumer packaged goods company recently finalized two key acquisitions related to the BrewDog brand. Earlier in March, Tilray acquired global assets from BrewDog, including its UK brewing operations and eleven brewpubs, for £33 million. This was followed this week by the completion of its purchase of BrewDog Brewing Australia, which includes a production facility in Brisbane and a network of company-owned and franchise bars.

Management views these transactions as foundational, creating a combined global beverage platform projected to generate approximately $500 million in annual revenue. The Australian acquisition is specifically intended to serve as a launchpad for expansion into the Asia-Pacific region.

New Product Launch and Cost-Saving Initiatives

Complementing its acquisition strategy, Tilray yesterday introduced "Pub Light," a low-calorie lager under its existing Pub Beer brand. The new product contains 99 calories and 4% alcohol by volume, aimed at price-conscious consumers. The company plans to scale distribution through its established North American network.

Internally, Tilray continues to execute its "Project 420" efficiency program, focused on realizing synergies and reducing costs. To date, the initiative has yielded savings of around $27 million, achieved through measures such as streamlining the product portfolio and optimizing the distributor network.

Cannabis Performance and the $1.2 Billion Revenue Goal

While building its beverage business, Tilray's cannabis segment remains a significant contributor. In January, the company reported record quarterly revenue of $218 million for its second fiscal quarter, driven by international medical cannabis and the Canadian recreational market. The potential for federal rescheduling of cannabis in the United States remains an open regulatory question that could impact the medical segment.

The overarching corporate objective is to achieve total annual revenue of $1.2 billion by fiscal year 2027. This growth is designed to gradually reduce the company's reliance on its cannabis operations. In a further step to bolster its beverage capabilities, Tilray entered into a multi-year partnership with the Carlsberg Group in February 2026 for the production and distribution of certain products in the U.S.

The critical challenge for Tilray in the coming quarters will be integration. The successful and efficient incorporation of the newly acquired UK and Australian operations into the corporate structure is essential for making the 2027 revenue target a realistic achievement.